Melanoma/Skin Cancer News

New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.

It took more than 35 years for tumor-infiltrating lymphocytes, which Steven A. Rosenberg, MD, PhD, and colleagues first reported on in 1988 for the treatment of advanced melanoma, to progress enough to gain FDA approval.

Bin Zheng, PhD, has been appointed director of melanoma research in the department of biomedical sciences at Cedars-Sinai Cancer.

A new study finds that dupilumab is associated with an increased risk for cutaneous T-cell lymphoma in patients taking the drug for atopic dermatitis.

Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for the treatment of adults with unresectable or metastatic HER2-positive solid tumors who received previous systemic therapy and lack additional treatment options.

When viewing the solar eclipse on April 8, individuals in the United States should not only protect their eyes, but also their skin.

Pfizer Inc. and its chairman/CEO, Albert Bourla, PhD, will be awarded the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine during the American Association for Cancer Research Annual Meeting in San Diego.

Among patients with melanoma, untreated moderate to severe obstructive sleep apnea increased the risk for poor long-term prognosis of skin cancer, according to results published in CHEST.